2021/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2021, Issue 3

Original Research

Pharmacokinetics and bioequivalence of generic etoricoxib in healthy volunteers

Reasons for patients’ generic drug switching at the pharmacy counter: a pilot study

Review Article

A critical review of substitution policy for biosimilars in Canada

Microbiological, scientific and regulatory perspectives of hand sanitizers

Pilot Study

Use of biologicals in dermatology – following the agreed path or going off-piste? A brief report

Abstracted Scientific Content

An IPRP survey of the regulatory requirements for the waiver of in vivo bioequivalence studies of generic medicinal products in certain dosage forms

Research News

Biosimilar epoetin for cancer and chemotherapy-induced anaemia in the US

Source URL: https://gabi-journal.net/2021-3-gabi-journal-table-of-contents.html


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048